loading

Voyager Therapeutics Inc Stock (VYGR) Latest News

pulisher
Nov 27, 2024

Great Point Partners LLC Sells 641,574 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Empowered Funds LLC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Nov 26, 2024
pulisher
Nov 22, 2024

Voyager Therapeutics Inc earnings beat by $0.29, revenue topped estimates - Investing.com Nigeria

Nov 22, 2024
pulisher
Nov 22, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $17.00 Consensus Target Price from Analysts - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Nov 22, 2024
pulisher
Nov 21, 2024

Voyager Therapeutics to advance tau silencing gene therapy for Alzheimer’s disease - BioWorld Online

Nov 21, 2024
pulisher
Nov 20, 2024

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease - GlobeNewswire

Nov 20, 2024
pulisher
Nov 20, 2024

Voyager's New Alzheimer's Gene Therapy Shows 73% Tau Reduction in Key Study | VYGR Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 18, 2024

Voyager Therapeutics’ TRACER Platform Targets CNS Market: Here’s Why I’m Neutral (VYGR) - Seeking Alpha

Nov 18, 2024
pulisher
Nov 18, 2024

Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 Earnings Forecast for VYGR Issued By HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at Canaccord Genuity Group - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

When the Price of (VYGR) Talks, People Listen - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 15, 2024

Voyager Therapeutics stock hits 52-week low at $5.71 - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

EcoR1 Capital, LLC Increases Stake in Voyager Therapeutics Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

FY2024 Earnings Forecast for VYGR Issued By Leerink Partnrs - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Voyager Therapeutics' (VYGR) Buy Rating Reaffirmed at Canaccord Genuity Group - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Earnings call: Voyager Therapeutics focuses on neurological therapies By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics: Q3 Earnings Snapshot - Darien Times

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Reports Strong Q3 2024 Progress - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings: Revenue Soars to $24.63M, EPS Loss of $0.16 Beats Estimates - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Reports Third Quarter 2024 Financial and Operating Results - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Revenue Soars 435% in Q3, Secures $15M Novartis Deal | VYGR Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Nov 12, 2024
pulisher
Nov 10, 2024

Voyager Therapeutics (NASDAQ:VYGR) Cut to Hold at StockNews.com - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve

Nov 08, 2024
pulisher
Nov 06, 2024

Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Voyager Therapeutics to Present at 4 Major Healthcare Investor Conferences in November | VYGR Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Voyager Therapeutics (VYGR) to Report Q3 2024 Earnings on November 12 | VYGR Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily

Nov 05, 2024
pulisher
Nov 04, 2024

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - MSN

Nov 04, 2024
pulisher
Oct 28, 2024

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat

Oct 26, 2024
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):